Literature DB >> 33688681

The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape.

Darren P Martin1, Steven Weaver2, Houryiah Tegally3, Emmanuel James San3, Stephen D Shank2, Eduan Wilkinson3, Alexander G Lucaci2, Jennifer Giandhari3, Sureshnee Naidoo3, Yeshnee Pillay3, Lavanya Singh3, Richard J Lessells3, Ravindra K Gupta4,5, Joel O Wertheim6, Anton Nekturenko7, Ben Murrell8, Gordon W Harkins9, Philippe Lemey10, Oscar A MacLean11, David L Robertson11, Tulio de Oliveira3,12, Sergei L Kosakovsky Pond2.   

Abstract

The emergence and rapid rise in prevalence of three independent SARS-CoV-2 "501Y lineages", B.1.1.7, B.1.351 and P.1, in the last three months of 2020 prompted renewed concerns about the evolutionary capacity of SARS-CoV-2 to adapt to both rising population immunity, and public health interventions such as vaccines and social distancing. Viruses giving rise to the different 501Y lineages have, presumably under intense natural selection following a shift in host environment, independently acquired multiple unique and convergent mutations. As a consequence, all have gained epidemiological and immunological properties that will likely complicate the control of COVID-19. Here, by examining patterns of mutations that arose in SARSCoV-2 genomes during the pandemic we find evidence of a major change in the selective forces acting on various SARS-CoV-2 genes and gene segments (such as S, nsp2 and nsp6), that likely coincided with the emergence of the 501Y lineages. In addition to involving continuing sequence diversification, we find evidence that a significant portion of the ongoing adaptive evolution of the 501Y lineages also involves further convergence between the lineages. Our findings highlight the importance of monitoring how members of these known 501Y lineages, and others still undiscovered, are convergently evolving similar strategies to ensure their persistence in the face of mounting infection and vaccine induced host immune recognition.

Entities:  

Year:  2021        PMID: 33688681      PMCID: PMC7941658          DOI: 10.1101/2021.02.23.21252268

Source DB:  PubMed          Journal:  medRxiv


  9 in total

Review 1.  Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.

Authors:  Daniele Focosi; Fabrizio Maggi
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

Review 2.  One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.

Authors:  Fernando González-Candelas; Marie-Anne Shaw; Tung Phan; Urmila Kulkarni-Kale; Dimitrios Paraskevis; Fabio Luciani; Hirokazu Kimura; Manuela Sironi
Journal:  Infect Genet Evol       Date:  2021-04-26       Impact factor: 4.393

3.  Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France.

Authors:  Philippe Colson; Jacques Fantini; Nouara Yahi; Jeremy Delerce; Anthony Levasseur; Pierre-Edouard Fournier; Jean-Christophe Lagier; Didier Raoult; Bernard La Scola
Journal:  Arch Virol       Date:  2022-01-27       Impact factor: 2.685

4.  RT-qPCR detection of SARS-CoV-2 mutations S 69-70 del, S N501Y and N D3L associated with variants of concern in Canadian wastewater samples.

Authors:  Shelley W Peterson; Ravinder Lidder; Jade Daigle; Quinn Wonitowy; Codey Dueck; Audra Nagasawa; Michael R Mulvey; Chand S Mangat
Journal:  Sci Total Environ       Date:  2021-10-28       Impact factor: 10.753

5.  Emergence of SARS-CoV-2 Alpha lineage and its correlation with quantitative wastewater-based epidemiology data.

Authors:  Elena Radu; Amandine Masseron; Fabian Amman; Anna Schedl; Benedikt Agerer; Lukas Endler; Thomas Penz; Christoph Bock; Andreas Bergthaler; Julia Vierheilig; Peter Hufnagl; Irina Korschineck; Jörg Krampe; Norbert Kreuzinger
Journal:  Water Res       Date:  2022-03-06       Impact factor: 13.400

Review 6.  Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein.

Authors:  Kyle A Wolf; Jason C Kwan; Jeremy P Kamil
Journal:  mBio       Date:  2022-03-08       Impact factor: 7.786

7.  Iron dysregulation in COVID-19 and reciprocal evolution of SARS-CoV-2: Natura nihil frustra facit.

Authors:  Yash Gupta; Dawid Maciorowski; Brian Medernach; Daniel P Becker; Ravi Durvasula; Claudia R Libertin; Prakasha Kempaiah
Journal:  J Cell Biochem       Date:  2022-01-08       Impact factor: 4.480

8.  RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City.

Authors:  Matthew M Hernandez; Radhika Banu; Ana S Gonzalez-Reiche; Brandon Gray; Paras Shrestha; Liyong Cao; Feng Chen; Huanzhi Shi; Ayman Hanna; Juan David Ramírez; Adriana van de Guchte; Robert Sebra; Melissa R Gitman; Michael D Nowak; Carlos Cordon-Cardo; Ted E Schutzbank; Viviana Simon; Harm van Bakel; Emilia Mia Sordillo; Alberto E Paniz-Mondolfi
Journal:  J Mol Diagn       Date:  2022-05-04       Impact factor: 5.341

Review 9.  SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs.

Authors:  Samuel Alizon; Mircea T Sofonea
Journal:  J Evol Biol       Date:  2021-07-17       Impact factor: 2.516

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.